Johnson & Johnson today launched the Dual Control campaign in Asia Pacific to raise awareness about the importance of ...
High-risk pregnancies can be caused by age, pre-existing medical conditions, or factors beyond human control. Here's what to ...
Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ulcerative colitis patients in two phase 3 trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback